Beyondspring Pharmaceuticals, Inc.
Records under this name other than the patents Beyondspring Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.
Back to Beyondspring Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,596,169 | Cancer Treatment with Combination of Plinabulin and Taxane Formerly held In force · High confidence | In force | High confidence | |
| US 10,550,104 | Plinabulin Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 7,956,058 | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof Formerly held Term ended Term ended Jan 16, 2026 · From the USPTO record | Term ended | Term ended Jan 16, 2026 | From the USPTO record |
| US 7,674,903 | Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof Formerly held Term ended Term ended Dec 31, 2025 · High confidence | Term ended | Term ended Dec 31, 2025 | High confidence |
| US 7,935,704 | Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof Term ended Term ended Nov 10, 2025 · High confidence | Term ended | Term ended Nov 10, 2025 | High confidence |
| US 7,064,201 | Dehydrophenylahistins and Analogs Thereof and the Synthesis of Dehydrophenylahistins and Analogs Thereof Term ended Term ended Apr 7, 2024 · High confidence | Term ended | Term ended Apr 7, 2024 | High confidence |
| US 7,919,497 | Analogs of Dehydrophenylahistins and Their Therapeutic Use Term ended Term ended Apr 7, 2024 · High confidence | Term ended | Term ended Apr 7, 2024 | High confidence |
| US 8,247,552 | Analogs of dehydrophenylahistins and their therapeutic use Term ended Term ended Aug 1, 2023 · From the USPTO record | Term ended | Term ended Aug 1, 2023 | From the USPTO record |
| US 8,618,292 | Analogs of dehydrophenylahistins and their therapeutic use Term ended Ended no later than Aug 1, 2023 · From the USPTO record | Term ended | Ended no later than Aug 1, 2023 | From the USPTO record |
| US 6,972,289 | Cell Division Inhibitor and a Production Method Thereof Term ended Term ended Jun 14, 2021 · High confidence | Term ended | Term ended Jun 14, 2021 | High confidence |